• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Director Breber Pierre R bought $546,285 worth of shares (4,000 units at $136.57) (SEC Form 4)

    5/9/25 4:25:25 PM ET
    $CLX
    Specialty Chemicals
    Consumer Discretionary
    Get the next $CLX alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    Breber Pierre R

    (Last) (First) (Middle)
    1221 BROADWAY

    (Street)
    OAKLAND CA 94612-1888

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    CLOROX CO /DE/ [ CLX ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    05/07/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 05/07/2025 P 4,000 A $136.5713(1) 4,000 D
    Common Stock 5,000 I By Trust
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Explanation of Responses:
    1. This transaction was executed in multiple trades at prices ranging from $136.21 to $136.92. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
    By Cheryl Brice, Attorney-in-Fact for 05/09/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $CLX alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CLX

    DatePrice TargetRatingAnalyst
    1/7/2025$157.00Underweight → Equal Weight
    Wells Fargo
    11/6/2024$155.00 → $170.00Sell → Hold
    TD Cowen
    10/1/2024$174.00 → $187.00Hold → Buy
    Jefferies
    7/23/2024$122.00Sell
    TD Cowen
    6/24/2024$130.00Underperform
    Exane BNP Paribas
    4/2/2024$170.00 → $165.00Buy → Neutral
    Citigroup
    3/26/2024$145.00Underperform → Hold
    Jefferies
    3/1/2024$140.00Sell
    Goldman
    More analyst ratings

    $CLX
    SEC Filings

    See more
    • SEC Form 10-Q filed by Clorox Company

      10-Q - CLOROX CO /DE/ (0000021076) (Filer)

      5/5/25 4:45:05 PM ET
      $CLX
      Specialty Chemicals
      Consumer Discretionary
    • Clorox Company filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - CLOROX CO /DE/ (0000021076) (Filer)

      5/5/25 4:11:51 PM ET
      $CLX
      Specialty Chemicals
      Consumer Discretionary
    • Clorox Company filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

      8-K - CLOROX CO /DE/ (0000021076) (Filer)

      3/28/25 4:30:13 PM ET
      $CLX
      Specialty Chemicals
      Consumer Discretionary

    $CLX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Breber Pierre R bought $546,285 worth of shares (4,000 units at $136.57) (SEC Form 4)

      4 - CLOROX CO /DE/ (0000021076) (Issuer)

      5/9/25 4:25:25 PM ET
      $CLX
      Specialty Chemicals
      Consumer Discretionary
    • EVP - Chief Financial Officer Bellet Luc was granted 2,704 shares, increasing direct ownership by 29% to 12,178 units (SEC Form 4)

      4 - CLOROX CO /DE/ (0000021076) (Issuer)

      4/3/25 5:46:15 PM ET
      $CLX
      Specialty Chemicals
      Consumer Discretionary
    • New insider Bellet Luc claimed ownership of 9,474 shares (SEC Form 3)

      3 - CLOROX CO /DE/ (0000021076) (Issuer)

      4/3/25 5:43:11 PM ET
      $CLX
      Specialty Chemicals
      Consumer Discretionary

    $CLX
    Leadership Updates

    Live Leadership Updates

    See more
    • Clorox Announces Appointment of Julia Denman and Stephanie Plaines to its Board of Directors

      OAKLAND, Calif., May 18, 2022 /PRNewswire/ -- The Clorox Company (NYSE:CLX) today announced the appointment of Julia (Charter) Denman and Stephanie Plaines to its board of directors, bringing additional deep financial expertise and industry leadership experience. Denman, 51, brings nearly 30 years of leadership and financial experience in both the technology and consumer packaged goods sectors. As corporate vice president and head of internal audit, enterprise risk and compliance at Microsoft, she provides independent and objective assessments of the company's business strateg

      5/18/22 4:30:00 PM ET
      $CLX
      Specialty Chemicals
      Consumer Discretionary

    $CLX
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • CloroxPro Announces New Agreement with Vizient to Supply Range of Cleaning and Disinfecting Products

      New contract expands product solutions available to Vizient's diverse customer base PLEASANTON, Calif., May 8, 2025 /PRNewswire/ -- Clorox Professional (CloroxPro), the trusted makers of a broad portfolio of healthcare and commercial cleaning solutions, is proud to announce our new contract with Vizient, the nation's largest provider-driven healthcare performance improvement company. This new agreement reflects CloroxPro's commitment to supporting healthcare and cleaning professionals with expanded solutions to meet evolving needs. "CloroxPro is eager to bring our 110-year leg

      5/8/25 9:01:00 AM ET
      $CLX
      Specialty Chemicals
      Consumer Discretionary
    • Clorox Reports Q3 Fiscal Year 2025 Results, Updates Outlook

      Delivers lower-than-expected sales amid a challenging and volatile consumer and geopolitical environment while maintaining overall market shares and delivering its 10th consecutive quarter of gross margin expansion OAKLAND, Calif., May 5, 2025 /PRNewswire/ -- The Clorox Company (NYSE:CLX) today reported results for the third quarter of fiscal year 2025, which ended Mar. 31, 2025. Third-Quarter Fiscal Year 2025 Summary Following is a summary of key results for the third quarter, which reflect the prior divestitures of the Better Health Vitamins, Minerals and Supplements (VMS) and Argentina businesses. All comparisons are with the third quarter of fiscal year 2024 unless otherwise stated. Net

      5/5/25 4:10:00 PM ET
      $CLX
      Specialty Chemicals
      Consumer Discretionary
    • Clorox Announces May 5 Webcast of Third-Quarter Fiscal Year 2025 Results

      OAKLAND, Calif., April 9, 2025 /PRNewswire/ -- The Clorox Company (NYSE:CLX) will issue its third-quarter fiscal year 2025 results on May 5, 2025. Timing for the announcement will be as follows: 1:15 p.m. PT / 4:15 p.m. ET: Press release and prepared management remarks posted on the company's website2 p.m. PT / 5 p.m. ET: Live Q&A audio webcast for analysts with Chair and CEO Linda Rendle and Chief Financial Officer Luc BelletLinks to the webcast, press release and prepared remarks can be found at Clorox quarterly results. About The Clorox Company The Clorox Company (NYSE:CLX) champions people to be well and thrive every single day. Its trusted brands include Brita®, Burt's Bees®, Clorox®, F

      4/9/25 4:30:00 PM ET
      $CLX
      Specialty Chemicals
      Consumer Discretionary

    $CLX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Clorox Company (Amendment)

      SC 13G/A - CLOROX CO /DE/ (0000021076) (Subject)

      2/13/24 5:02:29 PM ET
      $CLX
      Specialty Chemicals
      Consumer Discretionary
    • SEC Form SC 13G/A filed by Clorox Company (Amendment)

      SC 13G/A - CLOROX CO /DE/ (0000021076) (Subject)

      2/9/23 11:15:26 AM ET
      $CLX
      Specialty Chemicals
      Consumer Discretionary
    • SEC Form SC 13G/A filed by Clorox Company (Amendment)

      SC 13G/A - CLOROX CO /DE/ (0000021076) (Subject)

      2/9/22 3:43:30 PM ET
      $CLX
      Specialty Chemicals
      Consumer Discretionary

    $CLX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Clorox upgraded by Wells Fargo with a new price target

      Wells Fargo upgraded Clorox from Underweight to Equal Weight and set a new price target of $157.00

      1/7/25 7:46:13 AM ET
      $CLX
      Specialty Chemicals
      Consumer Discretionary
    • Clorox upgraded by TD Cowen with a new price target

      TD Cowen upgraded Clorox from Sell to Hold and set a new price target of $170.00 from $155.00 previously

      11/6/24 6:16:23 AM ET
      $CLX
      Specialty Chemicals
      Consumer Discretionary
    • Clorox upgraded by Jefferies with a new price target

      Jefferies upgraded Clorox from Hold to Buy and set a new price target of $187.00 from $174.00 previously

      10/1/24 7:24:28 AM ET
      $CLX
      Specialty Chemicals
      Consumer Discretionary

    $CLX
    Financials

    Live finance-specific insights

    See more
    • Clorox Reports Q3 Fiscal Year 2025 Results, Updates Outlook

      Delivers lower-than-expected sales amid a challenging and volatile consumer and geopolitical environment while maintaining overall market shares and delivering its 10th consecutive quarter of gross margin expansion OAKLAND, Calif., May 5, 2025 /PRNewswire/ -- The Clorox Company (NYSE:CLX) today reported results for the third quarter of fiscal year 2025, which ended Mar. 31, 2025. Third-Quarter Fiscal Year 2025 Summary Following is a summary of key results for the third quarter, which reflect the prior divestitures of the Better Health Vitamins, Minerals and Supplements (VMS) and Argentina businesses. All comparisons are with the third quarter of fiscal year 2024 unless otherwise stated. Net

      5/5/25 4:10:00 PM ET
      $CLX
      Specialty Chemicals
      Consumer Discretionary
    • Clorox Declares Regular Quarterly Dividend of $1.22 Per Share

      OAKLAND, Calif., Feb. 25, 2025 /PRNewswire/ -- The Clorox Company (NYSE:CLX) announced today that its board of directors has declared a quarterly dividend of $1.22 per share on the company's common stock. The dividend is payable May 9, 2025, to shareholders of record as of the close of business on April 23, 2025. Clorox has a long history of providing value to its shareholders through regular dividend payments and annual dividend increases. About The Clorox Company The Clorox Company (NYSE:CLX) champions people to be well and thrive every single day. Its trusted brands include Brita®, Burt's Bees®, Clorox®, Fresh Step®, Glad®, Hidden Valley®, Kingsford®, Liquid-Plumr® and Pine-Sol® as well a

      2/25/25 7:15:00 PM ET
      $CLX
      Specialty Chemicals
      Consumer Discretionary
    • Clorox Reports Q2 Fiscal Year 2025 Results, Updates Outlook

      OAKLAND, Calif., Feb. 3, 2025 /PRNewswire/ -- The Clorox Company (NYSE:CLX) today reported results for the second quarter of fiscal year 2025, which ended Dec. 31, 2024. Alongside these results, the company also announced that Clorox and P&G have jointly decided to wind down the Glad® bags and wraps joint venture as of Jan. 31, 2026, and the company intends to acquire P&G's 20% interest in the venture at its termination.   Second-Quarter Fiscal Year 2025 Summary Following is a summary of key results for the second quarter, which reflect the lapping of the operational recovery following the August 2023 cyberattack. Results also reflect the prior divestitures of the Better Health Vitamins, Min

      2/3/25 4:10:00 PM ET
      $CLX
      Specialty Chemicals
      Consumer Discretionary

    $CLX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Breber Pierre R bought $546,285 worth of shares (4,000 units at $136.57) (SEC Form 4)

      4 - CLOROX CO /DE/ (0000021076) (Issuer)

      5/9/25 4:25:25 PM ET
      $CLX
      Specialty Chemicals
      Consumer Discretionary